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Abstract
Background: Despite its popularity, little is known about the measurement invariance of the 
Patient Health Questionnaire-9 (PHQ-9) across U.S. sociodemographic groups. Use of a screener 
shown not to possess measurement invariance could result in under-detection/treatment of 
depression, potentially exacerbating sociodemographic disparities in depression. Therefore, we 
assessed the factor structure and measurement invariance of the PHQ-9 across major U.S. 
sociodemographic groups.
Methods: U.S. population representative data came from the 2005–2016 National Health and 
Nutrition Examination Survey (NHANES) cohorts We conducted a measurement invariance 
analysis of 31,366 respondents across sociodemographic factors of sex, race/ethnicity, and 
education level.
Results: Considering results of single-group confirmatory factor analyses (CFAs), depression 
theory, and research utility, we justify a two-factor structure for the PHQ-9 consisting of a 
cognitive/affective factor and a somatic factor (RMSEA=0.034, TLI=0.985, CFI=0.989). Based on 
multiple-group CFAs testing configural, scalar, and strict factorial invariance, we determined that 
invariance held for sex, race/ethnicity, and education level groups, as all models demonstrated 
close model fit (RMSEA=0.025–0.025, TLI=0.985–0.992, CFI=0.986–0.991). Finally, for all steps 
ΔCFI was < −0.004, and ΔRMSEA was < 0.01.
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Conclusions: We demonstrate that the PHQ-9 is acceptable to use in major U.S. 
sociodemographic groups and allows for meaningful comparisons in total, cognitive/affective, and 
somatic depressive symptoms across these groups, extending its use to the community. This 
knowledge is timely as medicine moves towards alternative payment models emphasizing high-
quality and cost-efficient care, which will likely incentivize behavioral and population health 
efforts. We also provide a consistent, evidence-based approach for calculating PHQ-9 subscale 
scores.
Introduction
Depression is a top public health concern due to its high prevalence, chronicity, and grave 
ramifications. The lifetime prevalence of major depressive disorder (MDD) in the U.S. is 
16% (Kessler et al., 2003). Depression also disproportionately affects people with lower 
socioeconomic status (Lorant et al., 2003). The course of MDD is often chronic, with a 15-
year recurrence rate of 35% in the general population (Hardeveld, Spijker, De Graaf, Nolen, 
& Beekman, 2010). Its grave ramifications include increased disability, mortality, and 
societal costs. Depression is the second leading cause of disability (Ferrari et al., 2013), and 
associated with increased mortality risk (Cuijpers et al., 2014). Moreover, the total annual 
cost of depression has increased from $83 billion in 2000 to $210 billion in 2010 
(Greenberg, Fournier, Sisitsky, Pike, & Kessler, 2015; Greenberg et al., 2003).
These alarming observations have motivated efforts to improve the detection and 
management of depression by routinely administering screeners. In 2016, the U.S. 
Preventive Services Task Force (USPSTF) recommended depression screening in the general 
adult population (Siu et al., 2016). Accompanying editorials underscored the importance of 
“population screening” (Thase, 2016) while also critiquing the USPSTF statement for not 
specifying “the ideal screening interval and the settings with highest potential yield” 
(Reynolds & Frank, 2016, pg. 189). One widely-used, self-report depression screener that 
was designed for primary care is the Patient Health Questionnaire-9 (PHQ-9; Hirschtritt & 
Kroenke, 2017). The PHQ-9 was identified as the first choice screener for adults in the 
accompanying editorial (Thase, 2016). In addition to a depression screener, the PHQ-9 has 
been validated as a continuous measure of depressive symptom severity (Kroenke, Spitzer, 
& Williams, 2001). The push for increased depression screening is occurring in the context 
of medicine’s movement toward alternative payment models that emphasize high-quality 
and cost-efficient care (Ganguli & Ferris, 2018). It has been posited that behavioral health 
integration and population health management will be incentivized and thus more widely 
adopted under these emerging payment models (Burwell, 2015; Joynt Maddox, 2018; 
“Smarter Spending. Healthier People: Paying Providers for Value, Not Volume,” 2015). 
These potentially profound changes to the healthcare system will amplify the need for brief 
depression screeners known to operate in an unbiased manner in major sociodemographic 
groups in the U.S., especially considering depression is associated with high healthcare 
utilization and costs (Bock et al., 2014; Kroenke & Unutzer, 2017; Luber et al., 2000; Prina 
et al., 2015). Moreover, measurement-based care is a key pillar in evidence-based behavioral 
health integration programs that have not only improved depression outcomes but also have 
proven cost-effective (Kroenke & Unutzer, 2017).
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Despite its widespread use in research and clinical practice, surprisingly little is known 
about the psychometric performance of the PHQ-9 across major U.S. sociodemographic 
groups. An advanced statistical approach called multiple-group confirmatory factor analysis 
(CFA) can evaluate an instrument’s psychometric performance across groups through 
measurement invariance testing. Measurement invariance is the statistical property of 
measurement that signifies the same underlying construct is being measured across groups. 
If measurement invariance is established, it would demonstrate that PHQ-9 assesses the 
same construct across U.S. sociodemographic groups and that observed differences in 
PHQ-9 scores among these groups reflect true group differences in depressive symptoms. 
Thus, we could conclude that the PHQ-9 is acceptable to use in major U.S. 
sociodemographic groups and that the PHQ-9 allows for meaningful comparisons in 
depressive symptoms across these groups. However, if measurement invariance is not 
established, it would raise serious concerns regarding the validity and utility of the PHQ-9 
for population-level screening in the U.S. Widespread use of a depression screener shown 
not to possess measurement invariance would likely result in under-detection or over-
detection of depression in certain groups. Under-detection would lead to under-treatment of 
depression, which could increase sociodemographic disparities in depression care and 
outcomes (Kim, 2014; Simpson, Krishnan, Kunik, & Ruiz, 2007), whereas over-detection 
would lead to the wasting of limited treatment resources.
Although a few investigations have examined the measurement invariance of the PHQ-9, 
these studies have been limited in two ways. One, they have not examined a consistent factor 
structure, with some claiming the PHQ-9 has one factor (Baas et al., 2011; Cameron, 
Crawford, Lawton, & Reid, 2013; Crane et al., 2010; Galenkamp, Stronks, Snijder, & Derks, 
2017; González-Blanch et al., 2018; Huang, Chung, Kroenke, Delucchi, & Spitzer, 2006; 
Keum, Miller, & Inkelas, 2018; Merz, Malcarne, Roesch, Riley, & Sadler, 2011) and others 
claiming two factors (Petersen et al., 2015), making the generalizability of findings 
confusing. Two, they have utilized non-representative samples – namely, primary care 
patients (Huang et al., 2006), college students (Keum et al., 2018), people with HIV (Crane 
et al., 2010), Latina women (Merz et al., 2011), and non-U.S. samples (Baas et al., 2011; 
Cameron et al., 2013; Galenkamp et al., 2017; González-Blanch et al., 2018; Petersen et al., 
2015). Consequently, it is not known which PHQ-9 factor structure provides the best fit and 
justification across major U.S. sociodemographic groups and whether the PHQ-9 can be 
used in these groups without bias. To fill these gaps, we examined a large, diverse sample 
representative of the U.S. adult population and used a state-of-the-art analytic approach to 
determine the factor structure and measurement invariance of the PHQ-9 across sex, race/
ethnicity, and education level.
Methods
Study Design and Sample
The continuous National Health and Nutrition Examination Survey (NHANES) is a cross-
sectional, population-based study designed to assess the health and nutritional status of the 
U.S. population. Using stratified multistage probability sampling, NHANES enrolls a 
nationally representative sample of ~5,000 non-institutionalized civilians each year. Those 
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selected to participate are initially interviewed in their homes by trained personnel, who 
administer questionnaires using computer-assisted technology. One to two weeks after the 
household interview, respondents are asked to visit a Mobile Examination Center (MEC) to 
complete additional interviews, examinations, and laboratory assessments. See the 
NHANES website (www.cdc.gov/nchs/nhanes.htm) for further details.
We examined NHANES data from all survey years in which the PHQ-9 was administered 
(2005–2016). From the total sample (N=60,936), we selected all respondents aged 18+ years 
who had complete PHQ-9 data (n = 31,366; Table 1). This sample was used to determine the 
PHQ-9 factor structure and measurement invariance across sex. For our analyses across race/
ethnicity, our sample was 30,179, as we excluded the 1,187 respondents in the other/multi-
racial group (because this highly heterogeneous group would cloud result interpretation). For 
our analyses across education level, our sample was 31,344, as we excluded the 22 
respondents with missing data. The study was approved by the local institutional review 
board.
Measures
Depressive Symptoms—The PHQ-9 was administered during the face-to-face MEC 
interview to assess depressive symptoms over the last two weeks (Kroenke et al., 2001). 
Respondents indicated, on a 0–3 scale, the frequency with which they experienced the 
following symptoms: (1) anhedonia, (2) depressed mood, (3) sleep disturbance, (4) fatigue, 
(5) appetite changes, (6) low self-esteem, (7) concentration problems, (8) psychomotor 
disturbances, and (9) suicidal ideation. Total scores range from 0 to 27, with scores ≥10 
representing clinically significant depressive symptoms (Kroenke & Spitzer, 2002). 
Furthermore, the PHQ-9 is validated as a depressive symptom severity measure (total score 
1–4: minimal depression, 5–9: mild depression, 10–14: moderate depression, 15–19: 
moderately severe depression, and 20–27: severe depression; Kroenke et al., 2001). The 
PHQ-9 demonstrates high internal consistency and good sensitivity and specificity for 
identifying cases of MDD (Hirschtritt & Kroenke, 2017; Kroenke et al., 2001; Mitchell, 
Yadegarfar, Gill, & Stubbs, 2016; Moriarty, Gilbody, McMillan, & Manea, 2015; Zuithoff et 
al., 2010).
Sociodemographic Factors—Sex, race/ethnicity, and education level data were 
collected by NHANES personnel during the household interview. Sex was coded by 
NHANES personnel as either male or female. Race/ethnicity was assessed by two questions: 
(1) “Do you consider yourself to be Hispanic, Latino, or Spanish origin?”, and (2) “What 
race do you consider yourself to be?” Using responses to these questions, NHANES 
personnel classified respondents into five groups (non-Hispanic White, non-Hispanic Black, 
Mexican American, other Hispanic, other/multi-racial) for the 2005–2010 years and six 
groups (non-Hispanic Asian was added) for the 2011–2016 years.
Education level was assessed by the question: “What is the highest grade or level of school 
you have completed or the highest degree you have received?” Using responses to this 
question, NHANES personnel classified respondents into the following groups: those aged 
20+ years – less than 9th grade, 9th–12th grade with no diploma, high school graduate/GED 
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or equivalent, some college or associate degree, or college graduate or above; those aged 18–
19 years – never attended/kindergarten only, grade level ranging from 1st-12th grade with no 
diploma, high school graduate, GED or equivalent, or more than high school. We used the 
categories for respondents aged 20+ years to reclassify respondents aged 18–19 years.
Data Analysis
We performed CFAs using MPlus software (Muthén & Muthén, 2015). Consistent with 
current recommendations (Rhemtulla, Brosseau-Liard, & Savalei, 2012), we used the means 
and variance adjusted weighted least squares (WLSMV) estimation method due to the 
ordinal scale . To determine the factor structure, we conducted five single-group CFAs on 
our full sample (n = 31,366), each of which examined a plausible model that has received 
support (Model 1, Cameron, Crawford, Lawton, & Reid, 2008; Dum, Pickren, Sobell, & 
Sobell, 2008; Galenkamp et al., 2017; González-Blanch et al., 2018; Huang et al., 2006; 
Keum et al., 2018; Kocalevent, Hinz, & Brähler, 2013; Model 2, Chilcot et al., 2013; Elhai et 
al., 2012; Krause, Bombardier, & Carter, 2008; Petersen et al., 2015; Model 3, Baas et al., 
2011; Petersen et al., 2015; Model 4, Elhai et al., 2012; Petersen et al., 2015; Model 5 
Kalpakjian et al., 2009; Krause, Reed, & McArdle, 2010; Richardson & Richards, 2008; see 
Table 2). In justifying our baseline model, we considered fit indices (root mean square error 
of approximation [RMSEA], Tucker-Lewis index [TLI], and comparative fit index [CFI]) 
and current depression theory. To assess model fit, we used the following guidelines: For 
absolute fit indices (RMSEA), exact fit = 0.00, close fit = 0.01–0.05, acceptable fit = 0.05–
0.08, mediocre fit = 0.08–0.10, and poor fit = greater than 0.10; for relative fit indices (TLI 
and CFI), exact fit = 1.00, close fit = 0.95–0.99, acceptable fit = 0.90–0.95, mediocre fit = 
0.85–0.90, and poor fit = less than 0.85 (Hu & Bentler, 1999).
To determine the PHQ-9’s measurement invariance, we carried out the four steps described 
by Gregorich (2006) and Sass (2014) using single and multiple-group CFAs. In these steps, 
four models were tested sequentially, each representing a specific level of measurement 
invariance, going from the least to most restrictive level of invariance. First, we evaluated 
dimensional invariance (equivalence in the number of latent factors across groups) by 
separately fitting the selected baseline model to each sex, race/ethnicity, and education level 
group using a single-group CFA approach. Second, we evaluated configural invariance (the 
latent factors are indicated by the same items across groups) by simultaneously fitting the 
selected model to the groups within each sociodemographic factor (e.g., the model was 
simultaneously fit to men and women) using a multiple-group CFA approach. Third, we 
evaluated scalar invariance (equivalence in the meaning of the latent factors and in potential 
item response biases unrelated to the latent factors across groups) by imposing equality 
constraints on the factor loadings (correlation between the item and factor) and item 
thresholds (the ordinal equivalent of an item intercept) of the configural invariance model. 
Fourth, we evaluated strict invariance (equivalence in the item error estimates unexplained 
by the latent factors across groups) by further imposing equality constraints on item residual 
variances of the scalar invariance model.
Consistent with current recommendations, we used a < −0.004 change in CFI (ΔCFI), to 
determine whether measurement invariance held at each step (Rutkowski & Svetina, 2017). 
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If ΔCFI was < −0.004 from one step to the next (e.g., from configural to scalar invariance), 
indicating that adding more equality constraints did not substantially decrease model fit, we 
concluded that the latter model (e.g., scalar invariance) is not significantly worse. 
Conversely, if ΔCFI was ≥ −0.004, we selected the former model (e.g., configural 
invariance). As is also recommended, we used ΔRMSEA < 0.010, in conjunction with ΔCFI, 
for invariance testing (Rutkowski & Svetina, 2017).
Results
Depressive Symptoms and Sociodemographic Factors
The mean PHQ-9 total score was 3.20 (SD = 4.27), falling in the minimal depression range. 
Even so, 9% of respondents had a PHQ-9 total score ≥10, which is indicative of clinically 
significant depressive symptoms (Kroenke & Spitzer, 2002). As is presented in Table 1, the 
mean PHQ-9 total score for each group (2.23–3.92) also fell in the minimal depression 
range, and the percentage of respondents with clinically significant depressive symptoms 
ranged from 3.8–13.2%. The mean age was 47.5 years (SD =18.8). About half of the sample 
were women and non-White, and there was good representation across the education levels 
(see Table 1). Finally, all groups demonstrated a similar correlation between the somatic and 
cognitive/affective constructs.
PHQ-9 Factor Structure
We conducted single-group CFAs, assessing the factor structure for the PHQ-9. All five 
models demonstrated close model-data fit, as the RMSEAs fell within the 0.01–0.05 range 
and the TLIs and CFIs fell within the 0.95–0.99 range (Table 2). Based on the fit indices 
alone, all models were plausible; however, we advocate for a two-factor model. Because 
depression is a multifaceted disorder, the high correlation of the factors and the items most 
likely suggest a higher order factor of depression (Byrne, 2005), rather than a more 
simplistic one-factor solution. In addition, a two-factor model has research utility. 
Specifically, studies examining depressive symptoms clusters have found that they are 
differentially associated with various health-related outcomes (Case & Stewart, 2014; 
Holzapfel et al., 2008; Roest et al., 2013; Roest et al., 2011; Smolderen et al., 2009; Vrany, 
Berntson, Khambaty, & Stewart, 2015).
Because all two-factor models had similar model-data fit, we turned to current depression 
theory to guide our selection of the best model. Models 2–5 differ with respect to on which 
factor the psychomotor disturbances and concentration difficulties items load. Concentration 
difficulties refer to depression-related issues with attention (a domain of cognitive 
functioning) and are thus conceptualized as a cognitive symptom of depression (De Jonge, 
Mangano, & Whooley, 2007; Duivis, Vogelzangs, Kupper, de Jonge, & Penninx, 2013; Hoen 
et al., 2010; McIntyre et al., 2015). For this theoretical reason, we conclude it is more 
reasonable that the concentration difficulties item fall under the cognitive/affective factor, 
which rules out Model 4. Model 5, in which the psychomotor disturbances item loads on 
both factors, revealed that this item was a stronger indicator of the cognitive/affective factor 
(factor loading = 0.6) than the somatic factor (factor loading = 0.2). This finding is 
consistent with current views on the neurobiological underpinnings of depression-related 
Patel et al. Page 6













psychomotor disturbances (Drevets, 2001). Specifically, psychomotor disturbances are 
thought to arise from dysfunction in the same brain reward pathways that are thought to 
underlie anhedonia (Drevets, 2001), an affective symptom of depression (Treadway & Zald, 
2011). Thus, the psychomotor disturbances item theoretically justified under the PHQ-9 
cognitive/affective factor, ruling out Models 3 and 5. Therefore, we selected Model 2 (see 
Figure 1), which had factor loadings above 0.70, for subsequent testing.
PHQ-9 Measurement Invariance across Sex, Race/Ethnicity, and Education Level
To evaluate dimensional invariance, we separately fit Model 2 to each group using a single-
group CFA approach. All models demonstrated close fit (Table 3); therefore, this model 
served as a baseline for subsequent invariance testing.
To evaluate configural invariance, we simultaneously fit Model 2 to the groups within each 
sociodemographic factor by running three multiple-group CFAs. The models for sex, race/
ethnicity, and education level all demonstrated close fit (Table 4), and the factor loadings 
across the groups were similar (Table 5). These results demonstrate that the number of 
factors are indicated by the same pattern of item loadings across groups, meaning that Model 
2 exists across sex, race/ethnicity, and education level groups.
To evaluate scalar invariance, we further equated the factor loadings and item thresholds 
across sociodemographic groups from the configural model. The models for sex, race/
ethnicity, and education level all demonstrated close fit (Table 4). The ΔCFI (< −0.004) and 
ΔRMSEA (< 0.010) criteria were met for all three models, signifying that scalar invariance 
was established. These results demonstrate that there is equivalence in both the meaning of 
the latent factors and the systematic influences on item responses unrelated to the latent 
factors across groups.
To evaluate strict invariance, we equated the error variances of the three multiple group 
CFAs from the scalar model. Yet again, the models of sex, race/ethnicity, and education level 
all demonstrated close fit (Table 4). The ΔCFI (< −0.004) and ΔRMSEA (< 0.010) criteria 
were met for all three models, indicating that strict invariance was established. These results 
demonstrate that there is equivalence in the item error variances across groups.
Altogether, measurement invariance tests yield three conclusions. One, the PHQ-9 cognitive/
affective and somatic factors as specified in Figure 1 carry the same meaning across sex, 
race/ethnicity, and education level groups in U.S. adults. Two, it is defensible to compare 
PHQ-9 observed means and variances/covariances across sex, race/ethnicity, and education 
level groups (Gregorich, 2006). In other words, the PHQ-9 allows for meaningful 
comparisons in depressive symptoms across these major U.S. sociodemographic groups with 
minimal risk of bias. Three, our use of a two-factor solution demonstrates that it is 
defensible to compare PHQ-9 cognitive/affective and somatic subscale scores across these 
groups.
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Our study examined the factor structure and measurement invariance of the PHQ-9 across 
major U.S. sociodemographic groups. First, we justified a two-factor solution for the PHQ-9 
consisting of cognitive/affective and somatic factors. A subscale score for the cognitive/
affective factor can be computed by summing the responses to items 1 (anhedonia), 2 
(depressed mood), 6 (low self-esteem), 7 (concentration difficulties), 8 (psychomotor 
disturbances), and 9 (suicidal ideation). A subscale score for the somatic factor can be 
computed by summing items 3 (sleep disturbance), 4 (fatigue), and 5 (appetite changes). 
Future studies should consider standardizing subscale scores (i.e., z scoring) when 
comparing them.
Our two-factor solution differs from previous studies advocating for a one-factor solution 
(Dum et al., 2008; Galenkamp et al., 2017; González-Blanch et al., 2018; Huang et al., 2006; 
Keum et al., 2018; Kocalevent et al., 2013). Three of these studies (Dum et al., 2008; Huang 
et al., 2006; Kocalevent et al., 2013) used principal component analysis, which is 
mathematically inappropriate (Brown, 2014). The studies that used CFA did not consider the 
research utility of a two-factor solution. Specifically, investigations using the PHQ-9 have 
found that depressive symptom clusters are differentially associated with various health-
related outcomes (Case & Stewart, 2014; Holzapfel et al., 2008; Roest et al., 2013; Roest et 
al., 2011; Smolderen et al., 2009; Vrany et al., 2015). Consistent with CFA 
recommendations (Brown, 2014), our study takes into consideration empirical evidence, 
current theory, and practical utility. Nonetheless, the PHQ-9 total score currently has high 
clinical utility, and future research is needed to compare the utility of the total and subscale 
scores in different clinical scenarios (e.g., screening versus monitoring).
Second, we established strict measurement invariance for the PHQ-9 across major U.S. 
sociodemographic groups. Therefore, the observed differences in the PHQ-9 total, cognitive/
affective, and somatic scores among these groups reflect true group differences in these 
depressive symptoms. The findings we report support the conclusions that (a) the PHQ-9 is 
acceptable to use in major sociodemographic groups in the U.S. and that (b) the PHQ-9 
allows for meaningful comparisons in total, cognitive/affective, and somatic depressive 
symptoms across these groups with minimal risk of bias. Although we tested measurement 
invariance using a two-factor solution, it is still appropriate to compute and use the single 
PHQ-9 total score for research, clinical, or other purposes across the examined groups, as 
the high correlation among the factors and items implies a higher order factor of depression 
(Byrne, 2005). However, it may be useful in future research to explicitly test this 
assumption.
As with all studies, ours is not without limitations. First, although we use a large U.S. 
representative sample, there were missing values which could limit the generalizability of 
findings. However, missingness in the sample was below the 10% guideline (Little, 
Jorgensen, Lang, & Moore, 2013). Second, due to the cross-sectional nature of the 
NHANES data, we were not able to assess measurement invariance overtime, as done by 
González-Blanch et al. (2018). Future studies are needed to determine whether measurement 
invariance of the selected two-factor solution for the PHQ-9 holds overtime. Third, age was 
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beyond the scope of this study, future investigations are needed to determine the factor 
structure and measurement invariance of the PHQ-9 across various categorizations for age 
groups.
Conclusion
We extend previous research validating the PHQ-9 as a depression screener and severity 
measure by determining its factor structure in U.S. adults and its measurement invariance 
across sex, race/ethnicity, and education level groups. Our findings demonstrate that the 
PHQ-9 is acceptable to use in major sociodemographic groups in the U.S. and allows for 
meaningful comparisons in total, cognitive/affective, and somatic depressive symptoms 
across these groups, extending the PHQ-9’s use from the clinic to the community. This 
knowledge is especially useful and timely as medicine moves toward wider adoption of 
alternative payment models emphasizing high-quality and cost-efficient care, which will 
likely incentivize behavioral health integration and population health management. Finally, 
we also provide a consistent, evidence-based approach for computing PHQ-9 cognitive/
affective and somatic subscale scores, which should facilitate comparisons of results across 
studies and future meta-analytic efforts.
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Two-Factor Measurement Model of the Patient Health Questionnaire-9 (PHQ-9).On the 
right, the boxes represent the PHQ-9 items (indicator variables). Circular arrows that point 
back to the indicator variables represent item error variances. Moving to the left, 
unidirectional linear arrows pointing from circles to boxes represent standardized factor 
loadings. The circles represent latent factors. Circular arrows that point back to the latent 
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factors represents latent variances (fixed to 1.0 for identification purposes, as demonstrated 
by the asterisk). The bidirectional arrow between latent factors represents a correlation
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Table 3
Confirmatory Factor Analysis Models and Fit Indices Evaluating Dimensional Invariance of the Patient Health 
Questionnaire-9 (PHQ-9) across Sex, Race/Ethnicity, and Education Level in U.S. Adults
χ2 Df p-value RMSEA RMSEA 90% CI TLI CFI
Sex n = 31,366
Women 638.62 26 0.000 0.038 0.036–0.041 0.984 0.988
Men 427.30 26 0.000 0.032 0.029-0.034 0.986 0.990
Race/Ethnicity n = 30,179
Non-Hispanic White 556.47 26 0.000 0.039 0.036-0.042 0.983 0.988
Non-Hispanic Black 247.90 26 0.000 0.035 0.031-0.040 0.986 0.990
Non-Hispanic Asian 79.24 26 0.000 0.034 0.026-0.043 0.982 0.987
Mexican American 177.50 26 0.000 0.033 0.029-0.038 0.987 0.990
Other Hispanic 113.44 26 0.000 0.034 0.027-0.040 0.988 0.991
Education Level n = 31,344
Less than 9th grade 98.54 26 0.000 0.030 0.024-0.036 0.990 0.993
9th to 12th grade (no diploma) 213.14 26 0.000 0.038 0.033-0.043 0.981 0.986
High school graduate/GED 
equivalent 266.67 26 0.000 0.035 0.032-0.039 0.986 0.990
Some college or associate degree 350.29 26 0.000 0.037 0.034-0.041 0.984 0.989
College graduate or above 159.61 26 0.000 0.028 0.024-0.032 0.986 0.990
Note. We used the two-factor Model 2 shown in Figure 1. For absolute fit indices (RMSEA), exact fit = 0.00, close fit = 0.01–0.05, acceptable fit = 
0.05–0.08, mediocre fit = 0.08–0.10, and poor fit = greater than 0.10. For relative fit indices (TLI and CFI), exact fit = 1.00, close fit = 0.95–0.99, 
acceptable fit = 0.90–0.95, mediocre fit = 0.85–0.90, and poor fit = less than 0.85. RMSEA = root mean square error of approximation. CI = 
confidence interval. TLI = Tucker-Lewis index. CFI = comparative fit index
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